03 . 10 .2023
News story
“A product for any type of skin”: celebrating Cetaphil’s range and reliability
02 . 10 .2023
News story
Alastin Skincare: Galderma announces launch in the UK and direct distribution and expansion in Canada
02 . 10 .2023
Press release
Galderma announces progress with RelabotulinumtoxinA regulatory submissions
14 . 09 .2023
Press release
Galderma launches advanced new serum with ALASTIN Skincare® - C-RADICAL Defense Antioxidant Serum
12 . 09 .2023
Press release
Powered by Peptides: Galderma introduces Cetaphil Healthy Renew, a retinol alternative skincare range
29 . 07 .2023
Press release
Galderma reiterates its commitment to commercialize and continue developing the broadest Injectable Aesthetics portfolio on the market, following Ipsen's recent announcement
27 . 07 .2023
Press release
Galderma achieves record 2 B USD net sales for a six-month period in H1 2023, as it continues to demonstrate leading execution and innovation capabilities in dermatology
04 . 07 .2023
Press release
Galderma @ WCD 2023: late-breaking phase III results for nemolizumab monotherapy in prurigo nodularis show a significant proportion of itch-free patients by week 4